How Can a Behavioral Economics Lens Contribute to Implementation Science?
Implementation Science
Authors
Nathan Hodson, Byron J. Powell, Per Nilsen, Rinad S. Beidas
CHIBE Experts
Research Areas
You might also be interested in...
View all publications-
Friends with Health Benefits: A Field Experiment
Management ScienceApril 17, 2024 -
Co-Designing Strategies To Implement Long-Acting Injectable PrEP for Sexual Minority Men in Chicago: A Study Protocol for an Innovation Tournament and Implementation Mapping
Implementation Science CommunicationsMarch 25, 2024 -
Adolescent Preferences for a Pediatric Primary Care-Based Sexually Transmitted Infection and HIV Prevention Intervention
Journal of Adolescent HealthMarch 24, 2024 -
Measuring Quality-Weighted Hospital-Free-Days in Acute Respiratory Failure: A Modified Delphi Study
Annals of the American Thoracic SocietyMarch 20, 2024 -
Field Testing the Transferability of Behavioural Science Knowledge on Promoting Vaccinations
Nature Human BehaviourMarch 14, 2024 -
The Next Decade of Healthcare
HealthcareFebruary 29, 2024 -
Health Care Resource Utilization and Costs Associated With Diagnosed Medication Overuse Headache and Potential Acute Medication Overuse in Individuals With Migraine
CephalalgiaFebruary 27, 2024 -
Evaluating the Implementation of a Community Health Worker-Delivered Intervention Integrating Asthma Care in West Philadelphia Public Schools
Journal of AsthmaFebruary 9, 2024 -
Real-World Survival, Healthcare Resource Utilization, and Costs Among U.S. Elderly Patients With Diffuse Large B-Cell Lymphoma (DLBCL) Treated With R-GemOx in the Relapsed/Refractory Setting
Clinical Lymphoma Myeloma LeukemiaFebruary 8, 2024 -
A Social Network Analysis of Hemodialysis Clinics: Attitudes Towards Living Donor Kidney Transplant Among Influential Patients
Kidney360February 7, 2024 -
Officer-Involved Killings of Unarmed Black People and Racial Disparities in Sleep Health
JAMA Internal MedicineFebruary 5, 2024 -
Real-World Analysis of Adverse Event Rates After Initiation of Ibrutinib Among Medicare Beneficiaries With Chronic Lymphocytic Leukemia
Cancer MedicineFebruary 1, 2024